NGEN – nervgen pharma corp. - common stock (US:NASDAQ)

News

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
NervGen Pharma to Participate at Upcoming Investor Conferences [Yahoo! Finance]
NervGen Pharma to Participate at Upcoming Investor Conferences
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
NervGen Pharma to Present at Unite2Fight Paralysis' 20th Annual Science and Advocacy Symposium [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com